These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. An oxanthroquinone derivative that disrupts RAS plasma membrane localization inhibits cancer cell growth. Tan L; Cho KJ; Neupane P; Capon RJ; Hancock JF J Biol Chem; 2018 Aug; 293(35):13696-13706. PubMed ID: 29970615 [TBL] [Abstract][Full Text] [Related]
5. Fendiline inhibits K-Ras plasma membrane localization and blocks K-Ras signal transmission. van der Hoeven D; Cho KJ; Ma X; Chigurupati S; Parton RG; Hancock JF Mol Cell Biol; 2013 Jan; 33(2):237-51. PubMed ID: 23129805 [TBL] [Abstract][Full Text] [Related]
6. Inhibitors of K-Ras plasma membrane localization. Cho KJ; van der Hoeven D; Hancock JF Enzymes; 2013; 33 Pt A():249-65. PubMed ID: 25033808 [TBL] [Abstract][Full Text] [Related]
7. Chalcones bearing a 3,4,5-trimethoxyphenyl motif are capable of selectively inhibiting oncogenic K-Ras signaling. Kovar SE; Fourman C; Kinstedt C; Williams B; Morris C; Cho KJ; Ketcha DM Bioorg Med Chem Lett; 2020 Jun; 30(11):127144. PubMed ID: 32276831 [TBL] [Abstract][Full Text] [Related]
8. 8-Hydroxyquinoline-based inhibitors of the Rce1 protease disrupt Ras membrane localization in human cells. Mohammed I; Hampton SE; Ashall L; Hildebrandt ER; Kutlik RA; Manandhar SP; Floyd BJ; Smith HE; Dozier JK; Distefano MD; Schmidt WK; Dore TM Bioorg Med Chem; 2016 Jan; 24(2):160-78. PubMed ID: 26706114 [TBL] [Abstract][Full Text] [Related]
9. Structures, Biosynthesis, and Bioactivity of Oligomycins from the Marine-Derived Feng XY; Li JH; Li RJ; Yuan SZ; Sun YJ; Peng XP; Dong H; Lou HX; Li G J Agric Food Chem; 2024 Jan; 72(2):1082-1095. PubMed ID: 38169320 [TBL] [Abstract][Full Text] [Related]
10. Selective growth inhibition by suppression of F1Fo ATPase in canine malignant melanoma cell lines. Kuroki S; Kobayashi M; Tani H; Miyamoto R; Kurita S; Tamura K; Ono K; Washizu T; Bonkobara M J Vet Pharmacol Ther; 2017 Jan; 40(1):101-104. PubMed ID: 27292541 [TBL] [Abstract][Full Text] [Related]
11. Study on retroaldol degradation products of antibiotic oligomycin A. Lysenkova LN; Turchin KF; Korolev AM; Danilenko VN; Bekker OB; Dezhenkova LG; Shtil AA; Preobrazhenskaya MN J Antibiot (Tokyo); 2014 Feb; 67(2):153-8. PubMed ID: 24084683 [TBL] [Abstract][Full Text] [Related]
12. A novel acyclic oligomycin A derivative formed via retro-aldol rearrangement of oligomycin A. Lysenkova LN; Turchin KF; Korolev AM; Bykov EE; Danilenko VN; Bekker OB; Trenin AS; Elizarov SM; Dezhenkova LG; Shtil AA; Preobrazhenskaya MN J Antibiot (Tokyo); 2012 Aug; 65(8):405-11. PubMed ID: 22617550 [TBL] [Abstract][Full Text] [Related]
13. Verification of oligomycin A structure: synthesis and biological evaluation of 33-dehydrooligomycin A. Lysenkova LN; Saveljev OY; Grammatikova NE; Tsvetkov VB; Bekker OB; Danilenko VN; Dezhenkova LG; Bykov EE; Omelchuk OA; Korolev AM; Shchekotikhin AE J Antibiot (Tokyo); 2017 Jul; 70(8):871-877. PubMed ID: 28420869 [TBL] [Abstract][Full Text] [Related]
14. Vimentin and the K-Ras-induced actin-binding protein control inositol-(1,4,5)-trisphosphate receptor redistribution during MDCK cell differentiation. Dingli F; Parys JB; Loew D; Saule S; Mery L J Cell Sci; 2012 Nov; 125(Pt 22):5428-40. PubMed ID: 22946050 [TBL] [Abstract][Full Text] [Related]
15. Boron-based inhibitors of acyl protein thioesterases 1 and 2. Zimmermann TJ; Bürger M; Tashiro E; Kondoh Y; Martinez NE; Görmer K; Rosin-Steiner S; Shimizu T; Ozaki S; Mikoshiba K; Watanabe N; Hall D; Vetter IR; Osada H; Hedberg C; Waldmann H Chembiochem; 2013 Jan; 14(1):115-22. PubMed ID: 23239555 [TBL] [Abstract][Full Text] [Related]
17. Avicin G is a potent sphingomyelinase inhibitor and blocks oncogenic K- and H-Ras signaling. Garrido CM; Henkels KM; Rehl KM; Liang H; Zhou Y; Gutterman JU; Cho KJ Sci Rep; 2020 Jun; 10(1):9120. PubMed ID: 32499517 [TBL] [Abstract][Full Text] [Related]
18. Oligomycin F, a new immunosuppressive homologue of oligomycin A. Laatsch H; Kellner M; Wolf G; Lee YS; Hansske F; Konetschny-Rapp S; Pessara U; Scheuer W; Stockinger H J Antibiot (Tokyo); 1993 Sep; 46(9):1334-41. PubMed ID: 8226311 [TBL] [Abstract][Full Text] [Related]
19. Recent progress in developing small molecule inhibitors designed to interfere with ras membrane association: toward inhibiting K-Ras and N-Ras functions. Tamanoi F; Lu J Enzymes; 2013; 34 Pt. B():181-200. PubMed ID: 25034105 [TBL] [Abstract][Full Text] [Related]
20. Colorectal Carcinogenesis: Connecting K-RAS-Induced Transformation and CREB Activity In Vitro and In Vivo. Steven A; Heiduk M; Recktenwald CV; Hiebl B; Wickenhauser C; Massa C; Seliger B Mol Cancer Res; 2015 Aug; 13(8):1248-62. PubMed ID: 25934695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]